
    
      The purpose of this study is to determine the effects of IV L-arginine hydrochloride therapy
      in children with sickle cell disease (SCD) and vaso-occlusive pain events (VOE).
      Specifically, the impact on total opioid use (mg/kg) over the duration of their emergency
      department (ED) visit and hospital stay will be evaluated.
    
  